Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

被引：0
|
作者：
Uk, Keon Kean Uk [1 ]
Kim, Jin Young [1 ]
Do, Young Rok [1 ]
Song, Hong Suk [1 ]
Jeon, Young June [1 ]
Ryoo, Hun Mo [2 ]
Bae, Sung Hwa [2 ]
Kim, Jong Gwang [3 ]
Baek, Jin Ho [4 ]
Chae, Yee Soo [3 ]
Kim, Min Kyoung [5 ]
Lee, Kyung Hee [5 ]
Cho, Yoon Young [6 ]
机构：
[1] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[2] Daegu Catholic Univ Hosp, Taegu, South Korea
[3] Kyungpook Natl Univ Hosp, Taegu, South Korea
[4] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan 680749, South Korea
[5] Yeungnam Univ Hosp, Taegu, South Korea
[6] Dongguk Univ, Med Ctr, Gyeongju, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4659
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of paclitaxel and capecitabine (PX) combination as neoadjuvant chemotherapy for unresectable locally advanced gastric cancer.
    Ko, Yoon Ho
    Hong, Sook Hee
    Roh, Sang Young
    Song, Kyo Young
    Jung, Eun Sun
    Jeon, Hae Myung
    Park, Cho Hyun
    Hong, Young Seon
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
    Masashi Kanai
    Kenichi Yoshimura
    Takehiko Tsumura
    Masanori Asada
    Chihiro Suzuki
    Miyuki Niimi
    Shigemi Matsumoto
    Takafumi Nishimura
    Takashi Nitta
    Kentaro Yasuchika
    Kojiro Taura
    Yukiko Mori
    Akihiko Hamada
    Naoya Inoue
    Shinsuke Tada
    Kazuhiro Yanagihara
    Shujiro Yazumi
    Yukio Osaki
    Tsutomu Chiba
    Iwao Ikai
    Masanori Fukushima
    Shinji Uemoto
    Etsuro Hatano
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1429 - 1434
  • [33] Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer
    Mark K. Doherty
    Vincent C. Tam
    Mairéad G. McNamara
    Raymond Jang
    David Hedley
    Eric Chen
    Neesha Dhani
    Patricia Tang
    Hao-Wen Sim
    Grainne M. O’Kane
    Stephanie DeLuca
    Lisa Wang
    Theresa Pedutem
    Jennifer J. Knox
    British Journal of Cancer, 2022, 127 : 1473 - 1478
  • [34] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
    Kanai, Masashi
    Yoshimura, Kenichi
    Tsumura, Takehiko
    Asada, Masanori
    Suzuki, Chihiro
    Niimi, Miyuki
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Nitta, Takashi
    Yasuchika, Kentaro
    Taura, Kojiro
    Mori, Yukiko
    Hamada, Akihiko
    Inoue, Naoya
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    Ikai, Iwao
    Fukushima, Masanori
    Uemoto, Shinji
    Hatano, Etsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1429 - 1434
  • [35] Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer
    Doherty, Mark K.
    Tam, Vincent C.
    McNamara, Mairead G.
    Jang, Raymond
    Hedley, David
    Chen, Eric
    Dhani, Neesha
    Tang, Patricia
    Sim, Hao-Wen
    O'Kane, Grainne M.
    DeLuca, Stephanie
    Wang, Lisa
    Pedutem, Theresa
    Knox, Jennifer J.
    BRITISH JOURNAL OF CANCER, 2022, 127 (08) : 1473 - 1478
  • [36] Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer
    Cohen, RB
    Mueller, SC
    Haden, K
    de Souza, P
    CANCER INVESTIGATION, 2000, 18 (05) : 422 - 428
  • [37] Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
    Johannsen, M
    Sachs, M
    Roigas, J
    Hinke, A
    Staack, A
    Loening, SA
    Schnorr, D
    Wille, AH
    EUROPEAN UROLOGY, 2005, 48 (02) : 246 - 251
  • [38] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
  • [39] A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Yokomori, T
    Iwazaki, S
    Kawashima, Y
    Iwanami, K
    Yamada, T
    Kawate, S
    Hamada, K
    Sunose, Y
    Yoshida, M
    Horiguchi, J
    Iesato, H
    Kobayashi, M
    Morishita, Y
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1291 - 1296
  • [40] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Hyeong Su Kim
    Ho Young Kim
    Dae Young Zang
    Ho Suk Oh
    Jang Yong Jeon
    Ji Woong Cho
    Choong Kee Park
    Jong Hyeok Kim
    Min-Jeong Kim
    Hong Il Ha
    Jung Han Kim
    Boram Han
    Hunho Song
    Jung Hye Kwon
    Dae Ro Choi
    Joo Young Jung
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
12345